Cytochrome b Mutations That Modify the Ubiquinol-binding Pocket of the Cytochrome bc1 Complex and Confer Anti-malarial Drug Resistance in Saccharomyces cerevisiae
Open Access
- 1 April 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (17) , 17142-17148
- https://doi.org/10.1074/jbc.m500388200
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Safety of Atovaquone/Proguanil in Long-Term Malaria Prophylaxis of Nonimmune AdultsJournal of Travel Medicine, 2006
- Atovaquone-Proguanil versus Chloroquine-Proguanil for Malaria Prophylaxis in Nonimmune Pediatric Travelers: Results of an International, Randomized, Open-Label StudyClinical Infectious Diseases, 2004
- Molecular Basis for Atovaquone Binding to the Cytochrome bc 1 ComplexJournal of Biological Chemistry, 2003
- Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, NigeriaMalaria Journal, 2002
- Plasmodium falciparum: The Effects of Atovaquone Resistance on RespirationExperimental Parasitology, 2001
- The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burdenThe American Journal of Tropical Medicine and Hygiene, 2001
- Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasitesMolecular Microbiology, 1999
- Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)Biochemical Pharmacology, 1992
- Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1991
- Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitisAntimicrobial Agents and Chemotherapy, 1990